Does SINTILIMAB Cause Reactive capillary endothelial proliferation? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Reactive capillary endothelial proliferation have been filed in association with SINTILIMAB. This represents 1.1% of all adverse event reports for SINTILIMAB.
7
Reports of Reactive capillary endothelial proliferation with SINTILIMAB
1.1%
of all SINTILIMAB reports
1
Deaths
0
Hospitalizations
How Dangerous Is Reactive capillary endothelial proliferation From SINTILIMAB?
Of the 7 reports, 1 (14.3%) resulted in death.
Is Reactive capillary endothelial proliferation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SINTILIMAB. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does SINTILIMAB Cause?
Myelosuppression (127)
Nausea (77)
Rash (72)
Vomiting (68)
Off label use (64)
Hypothyroidism (62)
Diarrhoea (61)
Fatigue (60)
Anaemia (59)
Pyrexia (51)
What Other Drugs Cause Reactive capillary endothelial proliferation?
CAMRELIZUMAB (41)
CAPECITABINE (19)
CISPLATIN (19)
DOCETAXEL\DOCETAXEL ANHYDROUS (17)
OXALIPLATIN (11)
ATEZOLIZUMAB (10)
BEVACIZUMAB (10)
PEMBROLIZUMAB (7)
TORIPALIMAB (6)
LENVATINIB (5)
Which SINTILIMAB Alternatives Have Lower Reactive capillary endothelial proliferation Risk?
SINTILIMAB vs SIPONIMOD
SINTILIMAB vs SIPULEUCEL-T
SINTILIMAB vs SIROLIMUS
SINTILIMAB vs SIRUKUMAB
SINTILIMAB vs SITAGLIPTIN